These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 2812334)
1. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Stern MB; Braffman BH; Skolnick BE; Hurtig HI; Grossman RI Neurology; 1989 Nov; 39(11):1524-6. PubMed ID: 2812334 [TBL] [Abstract][Full Text] [Related]
2. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease? Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850 [TBL] [Abstract][Full Text] [Related]
4. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660 [TBL] [Abstract][Full Text] [Related]
6. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism. Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879 [TBL] [Abstract][Full Text] [Related]
8. The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders. Wadia PM; Howard P; Ribeirro MQ; Robblee J; Asante A; Mikulis DJ; Lang AE Can J Neurol Sci; 2013 May; 40(3):389-402. PubMed ID: 23603177 [TBL] [Abstract][Full Text] [Related]
9. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Gupta D; Saini J; Kesavadas C; Sarma PS; Kishore A Neuroradiology; 2010 Dec; 52(12):1087-94. PubMed ID: 20358367 [TBL] [Abstract][Full Text] [Related]
10. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846 [TBL] [Abstract][Full Text] [Related]
11. [MRI in Parkinson's disease and vascular parkinsonism--study on the lesion of substantia nigra]. Aotsuka A; Shinotoh H; Hirayama K; Ikehira H; Fukuda H Rinsho Shinkeigaku; 1991 Jun; 31(6):619-24. PubMed ID: 1934776 [TBL] [Abstract][Full Text] [Related]
13. A study of parkinsonism in multiple system atrophy: clinical and MRI correlation. Wakai M; Kume A; Takahashi A; Ando T; Hashizume Y Acta Neurol Scand; 1994 Oct; 90(4):225-31. PubMed ID: 7839806 [TBL] [Abstract][Full Text] [Related]
14. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy. Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022 [TBL] [Abstract][Full Text] [Related]
15. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome. Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391 [TBL] [Abstract][Full Text] [Related]
16. An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms. Arabia G; Morelli M; Paglionico S; Novellino F; Salsone M; Giofrè L; Torchia G; Nicoletti G; Messina D; Condino F; Lanza P; Gallo O; Quattrone A Mov Disord; 2010 Dec; 25(16):2728-34. PubMed ID: 20925073 [TBL] [Abstract][Full Text] [Related]
17. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes. Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167 [TBL] [Abstract][Full Text] [Related]